ARHGEF19, a critical player in cytoskeletal remodeling and cell motility, is regulated by a diverse array of chemical compounds, each contributing to its enhanced activity through distinct pathways. Growth factors like EGF and PDGF, by activating their respective receptor tyrosine kinases, initiate signaling cascades that intersect with ARHGEF19 pathways, leading to its activation. This activation is crucial for ARHGEF19's role in actin cytoskeleton remodeling and cell migration. Similarly, TGF-β, through its receptors and subsequent SMAD signaling, modulates ARHGEF19, enhancing its function in cellular migration and invasion. Insulin and VEGF, through their receptor-mediated signaling, activate downstream pathways like PI3K/AKT and VEGFR, respectively, which interact with ARHGEF19's signaling mechanisms. These interactions promote ARHGEF19's involvement in vital processes like cellular migration, adhesion, and angiogenesis.
Moreover, compounds like Forskolin, by elevating cAMP levels and activating PKA, lead to the phosphorylation of proteins within ARHGEF19's pathway, thus indirectly enhancing its activity in cytoskeletal reorganization. Phorbol esters like PMA, activating PKC, also contribute to the modulation of ARHGEF19's activity, especially in processes like actin polymerization. Bioactive lipids such as LPA and S1P, through their G protein-coupled receptors, activate Rho GTPases signaling pathways, in which ARHGEF19 plays a pivotal role, thus augmenting its function in cytoskeletal organization and cell motility. Additionally, the application of FAK inhibitors, such as PF-573,228, can result in compensatory activation of ARHGEF19, further highlighting its significance in cell migration and invasion processes. Thrombin and Wnt3a, through their respective receptors, also contribute to ARHGEF19's activation, reinforcing its role in platelet activation, vascular integrity, cell proliferation, and migration. Collectively, these activators, through their targeted effects on various signaling pathways, facilitate the enhancement of ARHGEF19-mediated functions, showcasing the intricate network of cellular signaling in regulating protein activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can interact with ARHGEF19's signaling pathways, promoting actin polymerization and cell motility processes ARHGEF19 is involved in. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin elevates cAMP levels, leading to the activation of PKA. PKA can phosphorylate proteins within ARHGEF19's pathway, indirectly enhancing its activity in cytoskeletal reorganization. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin activates the insulin receptor and downstream PI3K/AKT signaling, which can interface with ARHGEF19 signaling pathways, promoting its role in cellular migration and adhesion. | ||||||
Bis(pinacolato)diboron | 73183-34-3 | sc-252467 sc-252467A | 1 g 5 g | $43.00 $80.00 | ||
PDGF activates its receptor tyrosine kinase, leading to activation of downstream pathways that can upregulate ARHGEF19 activity, facilitating its role in cell proliferation and migration. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
TGF-β activates TGF-β receptors and downstream SMAD signaling pathways, which may intersect with ARHGEF19 pathways, enhancing its function in cellular migration and invasion. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $96.00 $334.00 | 50 | |
LPA, through its G protein-coupled receptors, can activate Rho GTPases signaling pathways where ARHGEF19 functions, enhancing its role in cytoskeletal organization and cell motility. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
S1P, binding to its receptors, initiates signaling cascades that can activate ARHGEF19, promoting its involvement in cytoskeletal rearrangement and endothelial barrier function. | ||||||
Thrombin from human plasma | 9002-04-4 | sc-471713 | 100 U | $230.00 | ||
Thrombin, through PAR receptors, can activate signaling pathways involving ARHGEF19, enhancing its role in platelet activation and vascular integrity. | ||||||